A detailed history of Hughes Financial Services, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Hughes Financial Services, LLC holds 4 shares of NBIX stock, worth $491. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Holding current value
$491
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025

BUY
$107.22 - $153.29 $428 - $613
4 New
4 $428,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Hughes Financial Services, LLC Portfolio

Follow Hughes Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hughes Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hughes Financial Services, LLC with notifications on news.